Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Biochim Biophys Acta. 2011 Jan 22;1813(5):913–921. doi: 10.1016/j.bbamcr.2011.01.017

Insights into Modulation of Calcium Signaling by Magnesium in Calmodulin, Troponin C and Related EF-hand Proteins

Zenon Grabarek 1
PMCID: PMC3078997  NIHMSID: NIHMS267424  PMID: 21262274

Abstract

The Ca2+-binding helix-loop-helix structural motif called EF-hand is a common building block of a large family of proteins that function as intracellular Ca2+ receptors. These proteins respond specifically to micromolar concentrations of Ca2+ in the presence of ~1000 fold excess of the chemically similar divalent cation Mg2+. The intracellular free Mg2+ concentration is tightly controlled in a narrow range of 0.5–1.0 mM, which at the resting Ca2+ levels is sufficient to fully or partially saturate the Ca2+ binding sites of many EF-hand proteins. Thus, to convey Ca2+ signals, EF-hand proteins must respond differently to Ca2+ than to Mg2+. In this review the structural aspects of Mg2+ binding to EF-hand proteins are considered and interpreted in light of the recently proposed two-step Ca2+-binding mechanism (Grabarek, Z., J. Mol. Biol. 346,1351,2005). It is proposed that, due to stereochemical constraints imposed by the two-EF-hand domain structure, the smaller Mg2+ ion cannot engage the ligands of an EF-hand in the same way as Ca2+ and defaults to stabilizing the apo-like conformation of the EF-hand. It is proposed that Mg2+ plays an active role in the Ca2+-dependent regulation of cellular processes by stabilizing the off state of some EF-hand proteins, thereby facilitating switching off their respective target enzymes at the resting Ca2+ levels. Therefore, some pathological conditions attributed to Mg2+ deficiency might be related to excessive activation of underlying Ca2+-regulated cellular processes.

Keywords: EF-hand, Ca2+-binding, calcium signaling, Mg2+-binding, magnesium deficiency


The EF-hand is a Ca2+-binding helix-loop-helix structural motif discovered by R.H. Kretsinger in the X-ray structure of parvalbumin [1]. It is a basic building unit of a large family of proteins that serve as intracellular Ca2+-receptors. These proteins undergo conformational changes upon binding Ca2+, which enables them to reversibly bind to and regulate the activity of various target enzymes. Paradoxically, parvalbumin, the first crystallized member of this family does not change its structure significantly on binding Ca2+ and appears to contribute to Ca2+-signaling only indirectly by buffering the cytosolic free Ca2+. Among the Ca2+-sensor proteins, troponin C (TnC) and calmodulin (CaM), each consisting of four EF-hand motifs, have served as models for extensive structure-function studies and our current understanding of the EF-hand is based to a large extent on these studies. The early work in the laboratory of the late Prof. Witold Drabikowski at the Nencki Institute of Experimental Biology in Warsaw has demonstrated that both TnC and CaM can be split by limited proteolysis into two approximately equal size fragments that retain their structure and Ca2+-binding properties [27]. Thus, this work has defined a pair of EF-hand motifs as a structurally independent, functional domain. Subsequently, the high resolution X-ray and NMR structures of TnC [810] and CaM [1114] provided a vivid demonstration of domain independence in these proteins, the functional significance of which became apparent when the details of TnC and CaM interactions with their target molecules were established [1520].

A pair of EF-hand motifs forms a structurally stable cooperative domain due to the network of hydrogen bonds that connect the Ca2+-binding loops (a short stretch of antiparallel β-sheet) and due to extensive hydrophobic contacts among the helices flanking the Ca2+-binding loops [21]. This EF-hand pairing pattern, first defined in the structure of parvalbumin [1], has been reproduced in all high-resolution structures of EF-hand proteins [22], and in model systems utilizing synthetic peptide analogs of EF-hands [2325]. The bond network directly connecting the two Ca2+ ions in the domain, collectively called EF-handβ-scaffold, plays an important role in the Ca2+-binding mechanism and, in a recently proposed two-step mechanism, it is viewed as critical for the Ca2+-induced conformational transitions, and thus for the Ca2+-signaling function of EF-hand proteins [26, 27]. An extensive discussion of the EF-hand proteins structure and function can be found in the recent review by Gifford et al [28].

The focus of the present review is the specificity of the EF-hand proteins, i.e. their ability to recognize Ca2+ signals in the cytosol in the presence of ~1000 fold excess of the chemically similar divalent cation Mg2+. This remarkable property is discussed in light of the EF-hand-β-scaffold model [26, 27], which implies that, due to specific constraints, Mg2+ cannot engage the ligands of the EF-hand in the same way as Ca2+ does. It is further proposed that Mg2+ may play an active role in the Ca2+-dependent regulation of cellular processes by stabilizing the off state of some EF-hand proteins, thereby facilitating switching off their downstream activity at the resting Ca2+ levels. Some pathological conditions attributed to Mg2+ deficiency might be related to excessive activation of underlying Ca2+-regulated cellular processes.

The EF-hand calcium switch

The mechanism of the Ca2+-induced conformational changes in EF-hand proteins has been the subject of extensive studies for several decades. Although numerous techniques have provided evidence for the Ca2+-dependent structural changes in TnC, CaM and other EF-hand proteins, the first comprehensive description of the Ca2+ switch came from Herzberg, Moult and James [29] on the basis of the crystal structure of TnC [8, 9]. The switch occurs in a two-EF-hand domain and involves a change in the relative orientation of the helices flanking the Ca2+-binding loops, thus causing a transition from a closed to an open domain conformation. This off to on transition leads to the exposure of a hydrophobic pocket that serves as a target interaction site (reviewed in [21, 22, 28]).

The HMJ-model provided a description of the Ca2+ switch, but has not explained the underlying mechanism. An important insight in this respect came from the work of Sykes and colleagues who pointed to the critical role of the invariant Glu residue in the 12th position of the Ca2+-binding loop [30, 31]. This residue contributes two oxygen atoms of its γ-carboxyl group to the coordination sphere of the Ca2+ ion (a bidentate ligand). The importance of this residue was also evident from the earlier experiments on CaM showing that substitutions of Glu12 with Gln or Lys in the four Ca2+-binding sites of CaM had deleterious effects on the Ca2+-binding affinity and target enzyme activation [3234]. More detailed information about the Ca2+-binding mechanism came from the X-ray structure of a CaM mutant, which had intact Ca2+-binding loops, but was locked with a disulfide bond in the closed, apo-like, conformation [26]. In that structure, the Glu12 ligand was found at some distance from the Ca2+ ion, thus providing evidence for direct coupling between that ligand and the movement of the C-terminal (exiting) helix of an EF-hand and opening of the domain. In that structure the relative position of the two Ca2+ ions with respect to each other was found to be the same as in the open-domain conformation. The inference from this observation was that the structure connecting the two bound Ca2+, which includes the invariant carbonyl oxygen ligand in the center of the loop (the Y metal coordinating position) and the short stretch of the β-sheet connecting the two Ca2+-binding loops provide a stable, conformation independent scaffold for Ca2+ binding [26]. Since each EF-hand can bind Ca2+ only in the space very narrowly defined by the β-scaffold, the helices flanking the Ca2+-binding loop have to move in order for the other ligands to reach the metal ion (Figure 1). This is consistent with the requirement for pairing of the EF-hand motifs in a domain. In a single EF-hand the Ca2+ ion would most likely affect the local loop conformation without any long-range energetically unfavorable helix movement. The proposed model referred to as the EF-hand-β-scaffold model (EFBS) emphasizes the importance of the structure connecting the two bound Ca2+ ions. The invariant backbone carbonyl oxygen ligand in the center of the loop (cf. Figure 1) defines the position of the bound Ca2+ because unlike other ligands it is virtually immobilized by the β-scaffold [26]. The hydrogen bonds of the β-scaffold are highly polarized [35, 36]; a property that imparts the carbonyl Y ligand with a partial negative charge, thus further facilitating Ca2+ coordination. According to the EFBS model, Ca2+ binding occurs in two steps. Initially the N-terminal flexible part of the Ca2+-binding loop coordinates the Ca2+ ion. In the next step, bond rotation in the β-scaffold, specifically a change in the dihedral ϕ,ψ angles of the residue in the 8th position of the loop, enables the side chain of the Glu residue in the 12th position to approach the Ca2+ ion [26]. The interaction of that last bidentate ligand with Ca2+ closes the Ca2+-binding loop and causes the exiting helix to move, which results in domain opening.

Figure 1.

Figure 1

The Ca2+-induced conformational change in site I of CaM. The structures of the N-terminal domain of human recombinant CaM in the Ca2+-bound form (PDB entry 1CLL, [112]) and apo form of rat recombinant CaM (PDB entry 1QX5, [113]) have been superimposed using the backbone atoms of the β-scaffold (see ref [27] for details). In this conformation independent frame of reference the movement of the helices and closing of the loop associated with Ca2+ coordination can be discerned. Note the large shift of the C-terminal bidentate ligand (Glu31). This shift is enabled by the backbone dihedral angle changes in the branched hydrophobic residues of the β-scaffold (Ile27 in site I of CaM), which work as a hinge [26].

There are still very few EF-hand proteins for which both the apo and the Ca2+-bound high-resolution X-ray structures are available. It is clear, however, that the large conformational changes characteristic of TnC and CaM are neither unique, nor common to all EF-hand proteins. In fact, there is a great variety of possible structural responses to Ca2+ [22, 27, 28, 37]. However, irrespective of the extent of the Ca2+-induced hydrophobic site exposure, or other more subtle structural changes, the bidentate Ca2+ coordination by the Glu residue in the last position of the Ca2+-binding loop is preserved. A comparison of the high resolution X-ray structures of various EF-hand proteins suggests also that a mechanism similar to that outlined by the EFBS model may operate not only in the canonical EF-hands, i.e. those containing 12 amino acids in the Ca2+-binding loop, but also in those that have 11, 13 or 14 amino acids in the loop [27]. In these unconventional EF-hands variations in the amino acid sequence, composition and ultimately conformation are limited to the N-terminal part of the Ca2+-binding loop, while the β-scaffold structure and the bidentate Ca2+-coordination by the C-terminal Glu are preserved. While several facets of the EFBS model are hypothetical at present and require experimental verification, the model appears to offer attractive possibilities for design of new experiments, which might lead to a better understanding of the EF-hand proteins function.

Calcium signaling in the presence of magnesium

Mg2+ is one of the three physiologically relevant metal ions that are known to bind to EF-hand proteins and to modulate their Ca2+binding properties. The other two are Zn2+ and Cu2+, which bind to some members of the S100 protein family [38]. The binding site for Zn2+ and Cu2+ is located at the interface between two S100 monomers, outside of the N-terminal Ca2+-binding loop, and involves His and Asp or Cys side chains in a tetrahedral coordination geometry [39, 40]. Apparently, different preferences for ligands and different coordination geometry effectively exclude Zn2+ and Cu2+ from competing with Ca2+ for the EF-hand Ca2+-binding sites.

The intracellular free Ca2+ concentrations fluctuate between 10−7 M at rest and 10−5 M during activation [41, 42]. In contrast, the free Mg2+ level is relatively constant and falls in a narrow range of 0.5–1.0 mM in most cells [43]. Interestingly, hormonal stimulation can induce large fluxes of Mg2+ through the cell membrane, which suggests that the total Mg2+ content in cells and, indirectly, the free Mg2+ concentrations are tightly regulated [44, 45]. Many EF-hand Ca2+-binding sites have Mg2+ dissociation constants in submillimolar range, thus can be expected to bind Mg2+ in the absence of competing Ca2+. This observation alone implies that the Mg2+-bound structure should be different from the Ca2+-bound structure. One of the two structures must represent the activated form of the protein (the on state) while the other must correspond to the off state, otherwise, for those EF-hand proteins that bind Mg2+ with appreciable affinity, no relaxation and therefore no Ca2+-signaling would be possible. Indeed, there is a large body of published data documenting differences between Ca2+ and Mg2+ binding and the resultant structural and functional effects for various EF-hand proteins. Some relevant observations for CaM and TnC are reviewed below and interpreted in light of the EF-hand-β-scaffold model in anticipation of arriving at some more general conclusions potentially applicable to other EF-hand proteins.

Mg2+ binding to calmodulin

Calmodulin is a ubiquitously expressed Ca2+ sensor protein responsible for the regulation of many crucial cellular processes [46]. Therefore, the Mg2+-binding properties of CaM have been the subject of great interest. A number of early studies with the use of diverse techniques provided evidence for Mg2+ binding to CaM and for significant structural differences between the Mg2+-bound and the Ca2+-bund forms of this protein [7, 4753]. There are large differences in the Mg2+-CaM binding constants reported by various authors (~102–104 M−1), however there is a consensus that Mg2+ has the opposite preference for the binding sites relative to Ca2+, i.e. site I in the N-terminal domain has the highest affinity for Mg2+ [5356]. For example, Tsai et al. have reported Ka=3.5×103 M−1 for the N-terminal domain and Ka=2–3×102 M−1 for the C-terminal domain [53]. On the basis of their NMR studies Malmendal et al. have concluded that nearly half of the sites in the N-terminal domain of CaM would be occupied by Mg2+ in resting eukaryotic cells [55]. They also suggested that Mg2+ binding might occur without ligation to the residue in the 12th loop position, consequently causing smaller structural changes. In another work from the same group, the apparent affinity for Ca2+ of the N-terminal domain of CaM was found to be significantly decreased at physiological Mg2+ levels, consistent with a model in which each site can bind either Ca2+ or Mg2+ [57]. Under specific conditions a significant population of a mixed Mg2+/Ca2+ state was found and the Ca2+ off-rate from this state was at least one order of magnitude faster than from the 2Ca2+ state. The mixed state was found to have a conformation more similar to the "closed" apo and 2Mg2+ states than to the "open" 2Ca2+ state [57]. A more complex view of the Ca2+/Mg2+ competition emerged from microcalorimetric studies [51, 5860]. Gilli et at. have found the thermodynamic parameters of Mg2+ and Ca2+ binding to CaM inconsistent with a simple competition mechanism and proposed that Mg2+ is an allosteric effector with respect to Ca2+ binding and that the four main Mg2+ binding sites are distinct from the EF-hand Ca2+ binding sites [60]. In the absence of high resolution X-ray structure of Mg2+-bound CaM it is not clear what exactly the distinction between the Mg2+ and Ca2+ binding sites might be. Perhaps the two different views could be reconciled by a model in which Mg2+ engages only a subset of the ligands that interact with Ca2+ and, as a result, stabilizes domain conformation that is very different from that induced by Ca2+.

There is evidence for a strong stabilization of both domains of CaM in the presence of Ca2+ or Mg2+, as reflected in a large increase in the unfolding temperature [61, 62]. For each metal, however, the stabilized conformation is different. Indeed, a simple test with a hydrophobic fluorescent probe bisANS can be used to demonstrate that Mg2+ binding does not induce domain opening in CaM, whereas Ca2+ does (Figure 2, cf. also ref. [50]). This highly specific effect of Ca2+ is apparently attributable to the ionic radius of the metal ion, i.e. those metals whose ionic radii are closest to Ca2+ (~1.0 Å) are able to substitute for Ca2+ in the activation of CaM target enzymes [63]. The final point that needs to be considered with respect to the potential Mg2+ effect on Ca2+-CaM signaling is the role of the target enzyme. There is ample evidence that Mg2+ decreases CaM s affinity for various model peptide targets, but perhaps more importantly, the extent of the effect depends on the type of the target [54, 56]. According to Martin et al. Mg2+ has a role in directing the mode of initial target binding preferentially to the C-domain of CaM, due to the opposite relative affinities for binding of Ca2+ and Mg2+ to the two domains. Thus, they concluded, Mg2+ amplifies the intrinsic differences of the domains in a target specific manner [56].

Figure 2.

Figure 2

Mg2+ does not induce domain opening in CaM and TnC. Fluorescence emission spectra of bisANS (4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid) alone and after addition of CaM (left) or C-TnC, the C-terminal domain fragment of rabbit skeletal TnC, in the presence of 1 mM CaCl2 or 10 mM MgCl2 and 0.5 mM EGTA were recorded at 20°C upon excitation at 394 nm in solution containing 0.1 M NaCl, 20 mM HEPES pH 7.0. Note a large increase in fluorescence of bisANS if the protein is added in the presence of CaCl2 but not in the presence of MgCl2

Mg2+ binding to troponin C

In contrast to CaM, which has multiple targets and many functions, troponin C is specifically expressed in striated muscles where, as a part of the F-actin bound regulatory troponin-tropomyosin complex, it functions as a Ca2+-activated trigger of muscle contraction [6466]. Although TnC, like CaM, is comprised of two independent domains, the difference in Ca2+ affinity between the domains is larger, which appears to provide a clear definition of their function [5, 67]. The lower affinity sites in the N-domain are considered Ca2+ specific and are directly involved in the regulatory function of TnC. There are conflicting reports on the effect of Mg2+ on the Ca2+-sensitivity of myofibrils and reconstituted thin filaments [67, 68]. In more recent model studies Mg2+ was found to compete with Ca2+ for the regulatory domain of skeletal TnC with the apparent dissociation constant Kd=2.2 mM [69]. The C-terminal domain contains the high affinity Ca2+-binding sites that also bind Mg2+, thus are called the Ca2+ /Mg2+ sites and are believed to play a structural role by providing stability to the troponin complex. [67, 7072]. The potential role of the Ca2+/Mg2+ sites in regulation of contraction was originally rejected due to the slow kinetics of Mg2+ dissociation from these sites (~8 s−1) which would be a rate limiting step for Ca2+ binding at these sites during activation [70]. The regulatory role of the N-domain has been confirmed by site directed mutagenesis [72, 73] however various observations suggest that the Ca2+ /Mg2+ sites also contribute to the mechanism of regulation. For example, in a reconstituted system the C-terminal domain fragment of TnC retains partial regulatory activity [7476]. There is evidence for a Ca2+-dependent communication between the TnC domains in the troponin complex [77] which most likely involves the interaction of the inhibitory segment of troponin I (a twelve-residue stretch that binds actin and inhibits actin-myosin ATPase) with helix E, the N-terminal helix of the Ca2+ /Mg2+ site III of TnC [20]. It is not clear if that interaction is affected in any way by the Mg2+ /Ca2+ exchange at the adjacent site. The apparent equilibrium binding constant for Mg2+ binding to the C-domain of TnC has been estimated at 5×103 M−1 in free TnC and 5×104 M−1 in the troponin complex [67], which is sufficiently high for these sites to be fully occupied by Mg2+ at the resting Ca2+ concentrations. Due to slow Mg2+ dissociation rate little Mg2+ /Ca2+ exchange can be expected during a single activation-relaxation cycle, however full exchange can occur during prolonged or repetitive contraction [70]. The C-domain of TnC has little structure in the apo form, however both Ca2+ and Mg2+ induce folding [5, 7880] and strong stabilization of that domain [61, 62]. Again, like for CaM, the Mg2+ bound conformation of the C-domain of TnC is closed, while the Ca2+-bound conformation is open (Figure 2). The open conformation of the C-domain of TnC, as detected by bisANS, is consistent with the crystal structure of TnC [8, 9] and is clearly required for the interaction of this domain with the N-terminal α-helical segment of troponin I in the presence of Ca2+ [19, 20, 81]. However, the closed conformation of that domain in +Mg2+ state poses a problem, because it would require dissociation (or a different type of interaction) of the troponin I N-terminal segment. No such dissociation is evident in the currently available low-resolution structure (7.0 Å) of the apo form of skeletal troponin core domain [20]. Also the NMR studies of cardiac C-domain complex with TnI peptide revealed a monodentate Mg2+ ligation by the conserved Glu12 and partial closure of the hydrophobic binding cleft around Ca2+-binding site IV [82]. These data might suggest that the closed domain Mg2+-bound structure detected in solution is sufficiently flexible to open and accommodate the interacting TnI helix. Alternatively, a high-resolution structure of a complete regulatory complex may be required to reveal the effects of Mg2+ /Ca2+ exchange at this domain. In favor of the latter interpretation are data on F1 isoform of TnC from stretch activated insect flight muscle, in which only site IV in the C-domain is functional, and Ca2+-binding to that site is required for the function of this protein [8385].

Structure of the Mg2+-bound EF-hand

Clearly, there is strong evidence for conformational differences between the Ca2+ and Mg2+ bound forms of CaM and TnC. Unfortunately these differences are difficult to interpret in structural terms because no X-ray structures of the Mg2+ bound forms of these proteins are available. In fact, currently there are only three X-ray crystallographic structures of the Mg2+-bound EF-hand proteins in the Protein Data Bank: parvalbumin, calbindin D9k (S100G, according to the recent update on nomenclature [86]) and the scallop myosin regulatory light chain (RLC). In the structure of S100G, Mg2+ is bound to the C-terminal Ca2+-specific EF-loop. The loop has extended conformation similar to that in the apo form and Mg2+ interacts only with the N-terminal ligands of the loop. The Glu12 is too far from the bound cation for its side chain to contribute to Mg2+ coordination. Instead, a water molecule is found at that position (PDB entry 1IG5, [87], cf. Figure 3). The helices are more tightly packed than in the Ca2+-bound form. Overall, the Mg2+ bound EF-hand conformation of S100G is highly reminiscent of the Ca2+ bound EF-hands in the disulfide locked CaM [26]. In the Mg2+ bound loop of parvalbumin (PDB entry 4PAL, [88], cf. Figure 3) the side chain of Glu12 is rotated 120 degrees to provide only one oxygen ligand for Mg2+ coordination as compared to the Ca2+-bound structure (PDB code 4CPV, [89], cf. Figure 3). The EF-hand conformation is essentially the same as that of the Ca2+-bound form. The transition from bidentate Ca2+ coordination to monodentate Mg2+ coordination by Glu12 is apparently related to the difference in ionic radii (1.06 Å for Ca2+ vs 0.72 Å for Mg2+ [90]) as demonstrated by molecular dynamics simulations [91]. These structures point to two very distinctive features of the Mg2+-bound vs. Ca2+-bound EF-hand conformations: i) The geometry of the Mg2+ coordination in both parvalbumin and S100G is octahedral, even though the two proteins accomplish this geometry in different ways. ii) The bidentate interaction with the Glu12 side chain, which is a defining characteristic of the Ca2+ complex, is absent in both Mg2+-protein complexes.

Figure 3.

Figure 3

Geometry of the equatorial plane of Ca2+ and Mg2+ complexes with an EF-hand.

A Schematic representation of an idealized metal oxygen complex. The radius of the sphere in the center (rMe) is related to the number (n) and the radius (rO) of the surrounding spheres by: rO/(rMe+rO)=sin(360/2n). For rO=1.52 Å (van der Waals radius of the oxygen atom) we obtain rMe=1.06 Å for n=5 and rMe=0.63 Å for n=4, which correlate well with the ionic radii for Ca2+ and Mg2+ obtained by X-ray crystallography (1.06 Å and 0.72 Å respectively [90]). Note that the relative orientation of the Glu12 ligand with respect to the invariant carbonyl oxygen of the EF-hand-β-scaffold (assigned here as number 1 at the top) depends on the coordination number. For and the two oxygen atoms of the bidentate Glu12 ligand (atoms numbered 2 and 3) occupy adjacent positions in the equatorial plane of the complex. This is the key feature of the complex that sets the direction of approach for the side chain of Glu12 and consequently the position of the exiting helix with respect to the β-scaffold (approximately 108° as marked by the arrows). A similar bidentate coordination of Mg2+ by Glu12 would not be possible due to a larger angle of approach (135°) which would require the exiting helix to move much farther away from the β-scaffold and possibly clash with the incoming helix. For the Ca2+ complex the O-Ca2+-O bond angle is 72°, as compared to 90° for the Mg2+ complex.

B The EF-loop of carp parvalbumin in the Ca2+-bound form (PDB entry 4CPV, [89] beta isoform pI=4.25) and pike parvalbumin in Mg2+-bound form (PDB entry 4PAL, [88] beta isoform pI=4.1) conformation. The equatorial plane of each complex is shown in a similar orientation as that in (A) with the carbonyl oxygen ligand of the β-scaffold (the Y coordinating position) at the top. The yellow and cyan spheres represent Ca2+ and Mg2+, respectively, and the red and magenta spheres are the oxygen atoms in direct contact with the metal ion. The backbone atoms of the 12 amino acids comprising the Ca2+-binding loop are shown in stick representation. For clarity, sidechain atoms (in stick representation) are shown only for Glu12. The ionic radii were set to 1.06 Å for Ca2+ (sevenfold coordination) and 0.72 Å for Mg2+ (sixfold coordination) according to Shannon [90]. For oxygen atoms the radius is set to 1.52 Å, which represents the van der Waals volume [114].

C The C-terminal Ca2+-binding site of bovine recombinant S100G (calbindin D9k) in the Ca2+-bound (PDB entry 4ICB, [115]) and Mg2+-bound (PDB entry 1IG5, [87]) conformation. The pink sphere in the +Mg2+ structure is the oxygen atom of a water molecule that substitutes for the Glu12 oxygen atoms, which are too far. These figures were generated with PyMol [116].

The Mg2+-bound structure of scallop myosin RLC (PDB code 1WDC [92]) shows a different and less frequent variant of the EF-hand motif featuring an Asp residue at position 12 instead of Glu. Paradoxically, this substitution makes an EF-hand specific for Mg2+ [93], or perhaps more aptly, the affinity for Ca2+ decreases to the extent that it becomes irrelevant in the physiological range of cellular free Ca2+ concentrations. The preference of the Mg2+ ion for a shorter side chain (Asp) in the last position of the loop is somewhat counterintuitive considering that the ionic radius of Mg2+ is ~30% smaller than Ca2+. One might expect that an Asp containing loop would have to compress significantly more, thus causing a larger shift of the exiting helix, as compared to that featuring Glu in the last position. This is not the case, however, since the Asp side chain only contributes a single oxygen atom to the octahedral coordination of Mg2+, therefore does not constrain significantly the loop conformation. The bidentate coordination that is required for Ca2+ is apparently not possible with the shorter Asp side chain. This subtle difference accounts for the reversed Mg2+/Ca2+ specificity of the RLC. Support for this interpretation comes from the work of Phillips and colleagues who have shown that substitution of Asp for Glu in the EF loop of parvalbumin causes a 100 fold decrease in Ca2+ affinity, a 10 fold increase in Mg2+ affinity, and that both complexes adopt octahedral coordination [94].

The two Mg2+-EF-hand complexes shown in Fig. 3 represent different domain structures in terms of the relative orientation of the helices flanking the Ca2+-binding loop. The S100G-Mg2+ complex resembles the closed domain, whereas the parvalbumin-Mg2+ complex is similar to the open domain conformation of CaM and TnC. Unfortunately, neither S100G, nor parvalbumin undergoes a large structural change upon Ca2+ binding. Thus, it is not clear if the conclusions based on these structures can be extrapolated to TnC, CaM and other regulatory EF-hand proteins. In particular, we are left with the following questions: 1) Why is there a change from bidentate to monodentate metal ion coordination by the carboxyl group in the 12th position? In principle, eliminating an oxygen ligand at any other coordinating position of the loop could fulfill the Mg2+ requirement for hexa-coordination. 2) What are the functional consequences of the transition from bidentate to monodentate Glu12 interaction with the metal ion?

Interpretation of the Ca2+/Mg2+ specificity based on the EF-hand-β-scaffold model

Differences in ionic radii, hydration and coordination geometry are generally listed among those properties that enable EF-hand proteins to discriminate between Ca2+ and Mg2+. The Mg2+ ion has ~30% smaller ionic radius as compared to Ca2+. However, owing to the tight ordering of water molecules the hydrated Mg2+ ion is approximately 400× larger in volume than its dehydrated form. In contrast, the hydrated Ca2+ ion is only ~25× larger [95]. The difference in hydration is important for ion transport [96] and for the kinetics of binding to the EF-hand. The exchange rate of solvent water around the hydrated Mg2+ is 3–4 orders of magnitude slower than for Ca2+ [95]. Thus, the Mg2+ binding on-rate is limited by the dehydration rate, which accounts for the generally weak binding of Mg2+ to proteins and small molecules. As discussed earlier, many EF-hand Ca2+-binding sites have sufficiently high affinity for Mg2+ to be partially or fully saturated with Mg2+ at the resting Ca2+ concentrations. The key factor for effective Ca2+ signaling is the difference in the resultant EF-hand conformation, which in turn must be related to the ionic radius and the coordination geometry of the metal ion. The EFBS model offers a plausible explanation of the relation between these factors and why Mg2+ is generally unable to substitute for Ca2+.

Figure 3A illustrates the distribution of atoms in the equatorial plane of an idealized metal ion-oxygen complex. The larger Ca2+ ion can accommodate 5 oxygen atoms whereas only four oxygen atoms can fit in a plane around the smaller Mg2+. This difference can be rationalized most simply in the following way: The radius of the sphere in the center (rMe) is related to the number (n) and the radius (rO) of the surrounding spheres by: rO/(rMe+rO)=sin(360/2n). For rO=1.52 Å (van der Waals radius of the oxygen atom) we obtain rMe=1.06 Å for n=5 and rMe=0.63 Å for n=4, which correlate well with the ionic radii for Ca2+ and Mg2+ obtained by X-ray crystallography (1.06 Å and 0.72 Å respectively [90]). Clearly, upon substitution of Ca2+ with Mg2+ one of the oxygen ligands has to be removed. There appear to be two reasons why it is the bidentate Glu12 ligand that is reduced to monodentate interaction.

The first reason is related to the fixed position of the carbonyl oxygen ligand of the β-scaffold (assigned arbitrarily as number 1 in Figure 3A). The two oxygen atoms of the bidentate Glu12 ligand (atoms numbered 2 and 3 in Figure 3A) occupy adjacent positions in the equatorial plane of the complex. This is the key feature of the complex that sets the direction of approach for the side chain of Glu12 and consequently the position of the exiting helix with respect to the β-scaffold (approximately 108° as marked by the arrows). A similar bidentate coordination of Mg2+ by Glu12 would not be possible because it would require the exiting helix to move much farther away from the β-scaffold (marked with a dashed arrow in Figure 3A) and possibly clash with the incoming helix. A change to a monodentate interaction of Glu12 positions that residue at ~90° with respect to the carbonyl oxygen ligand and also permits more flexibility to the Glu12 side chain and ultimately to the exiting helix.

The second reason for the switch from bidentate for Ca2+ to monodentate for Mg2+ Glu12 -metal ion interaction may be related to the difference in the Me-O bond lengths and, consequently, Me-O-C bond angles. Analysis of the Ca2+-carboxylate interactions in crystal structures of calcium complexes indicates a relatively broad distribution of bond lengths (2.3–2.7 Å) and angles (110° 170°) for monodentate Ca2+-carboxylate interactions. In contrast, a bidentate Ca2+-carboxylate interaction sets the Ca2+-O-C bond angle at 90° [97]. Due to the smaller ionic radius, thus a shorter O-Me distance for Mg2+ the Mg2+-O-C angle would have to be significantly less than 90° for bidentate interaction, which apparently is unfavorable. Analysis of high-resolution X-ray crystallographic structures of small molecules containing carboxyl-metal ion complexes indicates that bidentate interaction is virtually excluded for carboxyl-Mg2+ interaction. In contrast, Ca2+ frequently forms bidentate complexes with carboxylates [98].

Functional implications

There are several ways in which Mg2+ may affect the function of EF-hand proteins. The simplest effect is a decrease in the apparent binding constant for Ca2+ due to Mg2+ competition for the binding sites, which in turn will cause a shift of the target enzyme activation curve to higher Ca2+ concentrations often referred to as a decrease in Ca2+ sensitivity . The extent of the effect depends on the Mg2+ binding constant and the Mg2+ concentration and can be calculated from the relation: K Ca=KCa/(1+KMg.[Mg2+]), where KCa and K Ca are the binding constants for Ca2+ in the absence and presence of Mg2+, and KMg is the binding constant for Mg2+. This relation holds true for a single, or independent site. In reality, the relation is likely to be more complex due to the fact that Ca2+ binds cooperatively to CaM, TnC and other EF-hand proteins. Furthermore there is evidence for negative allostery between Mg2+ and Ca2+ [57, 87], as reflected in the faster dissociation of Ca2+ from the mixed Ca2+ /Mg2+ species. The problem of predicting Mg2+ effects is further compounded by the various preferences of the interacting target molecules (eg. ref. [56]). In view of the data in Fig. 2 and other published observations, Mg2+ clearly stabilizes the closed domain conformation of CaM. This apparently is the preferred conformation for the group of targets that utilize the so-called IQ domain for CaM binding [99]. Recent studies by Persechini and colleagues suggest a switching mechanism in which each domain of CaM plays a specific and different role in each of its conformations [100]. It is likely that Mg2+ may further diversify the Ca2+ signaling in these proteins due to specific modulation of the Ca2+ response of each domain [56]. Moreover, one may expect rather complex responses for various EF-hand protein-target systems in environments where Mg2+ concentrations change.

While it is important to consider the effects of Mg2+ on the EF-hand target interaction in order to interpret the in vitro binding parameters, the absolute effect of Mg2+ is perhaps of lesser importance from the physiological point of view. The important question is if small changes in intracellular Mg2+ concentrations might be expected to alter in any physiologically relevant manner the intracellular Ca2+-signaling. In other words how big an effect has to be in order to be physiologically relevant? Candidates include systems requiring very tight regulation of cellular responses. For example, in familial hypertrophic cardiomyopathy a small (pCa<0.1) increase in Ca2+ sensitivity of TnC regulated actin filaments leads to diminished quality of life and premature death [101]. Indeed, the function of the heart is not only regulated directly by precise Ca2+ transients, but also modulated in many ways by diverse signaling pathways, some of which are sensitive to Ca2+ [102]. Small effects at the many checking points of this complex system caused by changes in Mg2+ concentration may have a significant cumulative effect on the function of the heart. Other systems that seem likely to be affected by changing Mg2+ concentrations are those involving Ca2+-regulated cascades such as the CaM-kinase cascade [103], or the integrative systems that respond to cumulative effects of multiple small Ca2+ transients.

The total magnesium concentration in mammalian cells is 15–20 mM, thus making Mg2+ the second most abundant cellular cation after potassium. However, only a small fraction (~1 mM) of the total Mg2+ in cells is in the form of free ion [95]. Mg2+ is a cofactor in many intracellular processes by virtue of binding to ATP and other nucleotides. It is also involved in the catalytic function of many enzymes, contributes to the stability of proteins and mediates some specific protein-protein interactions. The intracellular Mg2+ concentrations are hormonally regulated [45, 104, 105], suggesting that Mg2+ homeostasis is of vital importance. There is extensive literature documenting a correlation between cellular or dietary Mg2+-deficiency and a number of pathological conditions [106]. In particular, Mg2+ deficiency has been correlated with cardiovascular diseases including heart attack, specific forms of cardiac arrhythmias, angina and congestive heart failure, as well as hypertension, inflammation, asthma, metabolic syndrome and many others [107110]. In some studies the protective effect of Mg2+ on cardiovascular system has been compared favorably to those of statin pharmaceuticals [111]. Although the important role of intracellular Mg2+ is recognized, the underlying biochemical and molecular mechanisms are not well understood.

Conclusion

The structural analysis presented in this review indicates that Mg2+ and Ca2+ have opposing effects on the structure and function of calmodulin, troponin C and related EF-hand Ca2+-binding proteins. Therefore Mg2+ may be an important factor in modulating the Ca2+-sensitivity and, in particular, switching off some Ca2+-regulated systems at the resting cellular Ca2+ levels. Although at this point it would be premature to make any specific connections, it is likely that some pathological conditions attributed to Mg2+ deficiency are related to excessive activation of underlying Ca2+-regulated cellular processes.

Acknowledgments

I am grateful to Franklin Fuchs, Philip Graceffa, Sarah Learman, Sam Lehrer and Timur Senguin for critical review of the manuscript.

This work was supported by the National Institutes of Health (grant HL-91162)

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Kretsinger RH, Nockolds CE. Carp muscle calcium binding protein. II. Structure determination and general description. J. Biol. Chem. 1973;248:3313–3326. [PubMed] [Google Scholar]
  • 2.Drabikowski W, Grabarek Z, Barylko B. Degradation of TN-C component of troponin by trypsin. Biochim. Biophys. Acta. 1977;490:216–224. doi: 10.1016/0005-2795(77)90122-2. [DOI] [PubMed] [Google Scholar]
  • 3.Drabikowski W, Kuznicki J, Grabarek Z. Similarity in Ca2+ -induced changes between troponic-C and protein activator of 3':5'-cyclic nucleotide phosphodiesterase and their tryptic fragments. Biochim. Biophys. Acta. 1977;485:124–133. doi: 10.1016/0005-2744(77)90199-1. [DOI] [PubMed] [Google Scholar]
  • 4.Walsh M, Stevens FC, Kuznicki J, Drabikowski W. Characterization of tryptic fragments obtained from bovine brain protein modulator of cyclic nucleotide phosphodiesterase. J. Biol. Chem. 1977;252:7440–7443. [PubMed] [Google Scholar]
  • 5.Leavis PC, Rosenfeld SS, Gergely J, Grabarek Z, Drabikowski W. Proteolytic fragments of troponin C. Localization of high and low affinity Ca2+ binding sites and interactions with troponin I and troponin T. J. Biol. Chem. 1978;253:5452–5459. [PubMed] [Google Scholar]
  • 6.Evans JS, Levine BA, Leavis PC, Gergely J, Grabarek Z, Drabikowski W. Proton magnetic resonance studies on proteolytic fragments of troponin-C. Structural homology with the native molecule. Biochim. Biophys. Acta. 1980;623:10–20. doi: 10.1016/0005-2795(80)90003-3. [DOI] [PubMed] [Google Scholar]
  • 7.Drabikowski W, Brzeska H, Venyaminov S. Tryptic fragments of calmodulin. Ca2+ -and Mg2+ -induced conformational changes. J Biol Chem. 1982;257:11584–11590. [PubMed] [Google Scholar]
  • 8.Herzberg O, James MN. Structure of the calcium regulatory muscle protein troponin-C at 2.8 A resolution. Nature. 1985;313:653–659. doi: 10.1038/313653a0. [DOI] [PubMed] [Google Scholar]
  • 9.Sundaralingam M, Bergstrom R, Strasburg G, Rao ST, Roychowdhury P, Greaser M, Wang BC. Molecular structure of troponin C from chicken skeletal muscle at 3-angstrom resolution. Science. 1985;227:945–948. doi: 10.1126/science.3969570. [DOI] [PubMed] [Google Scholar]
  • 10.Slupsky CM, Sykes BD. NMR Solution structure of calcium-saturated skeletal muscle troponin C. Biochemistry. 1995;34:15953–15964. doi: 10.1021/bi00049a010. [DOI] [PubMed] [Google Scholar]
  • 11.Babu YS, Sack JS, Greenhough TJ, Bugg CE, Means AR, Cook WJ. Three-dimensional structure of calmodulin. Nature. 1985;315:37–40. doi: 10.1038/315037a0. [DOI] [PubMed] [Google Scholar]
  • 12.Ikura M, Barbato G, Klee CB, Bax A. Solution structure of calmodulin and its complex with a myosin light chain kinase fragment. Cell Calcium. 1992;13:391–400. doi: 10.1016/0143-4160(92)90052-t. [DOI] [PubMed] [Google Scholar]
  • 13.Zhang M, Tanaka T, Ikura M. Calcium-induced conformational transition revealed by the solution structure of apo calmodulin. Nature Structural Biology. 1995;2:758–767. doi: 10.1038/nsb0995-758. [DOI] [PubMed] [Google Scholar]
  • 14.Kuboniwa H, Tjandra N, Grzesiek S, Ren H, Klee CB, Bax A. Solution structure of calcium-free calmodulin. Nature Structural Biology. 1995;2:768–776. doi: 10.1038/nsb0995-768. [DOI] [PubMed] [Google Scholar]
  • 15.Meador WE, Means AR, Quiocho FA. Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science. 1992;257:1251–1255. doi: 10.1126/science.1519061. [DOI] [PubMed] [Google Scholar]
  • 16.Ikura M, Clore GM, Gronenborn AM, Zhu G, Klee CB, Bax A. Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science. 1992;256:632–638. doi: 10.1126/science.1585175. [DOI] [PubMed] [Google Scholar]
  • 17.Drum CL, Yan SZ, Bard J, Shen YQ, Lu D, Soelaiman S, Grabarek Z, Bohm A, Tang WJ. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature. 2002;415:396–402. doi: 10.1038/415396a. [DOI] [PubMed] [Google Scholar]
  • 18.Crivici A, Ikura M. Molecular and structural basis of target recognition by calmodulin. [Review] Ann. Rev. of Biophys. Biomol. Struct. 1995;24:85–116. doi: 10.1146/annurev.bb.24.060195.000505. [DOI] [PubMed] [Google Scholar]
  • 19.Takeda S, Yamashita A, Maeda K, Maeda Y. Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature. 2003;424:35–41. doi: 10.1038/nature01780. [DOI] [PubMed] [Google Scholar]
  • 20.Vinogradova MV, Stone DB, Malanina GG, Karatzaferi C, Cooke R, Mendelson RA, Fletterick RJ. Ca(2+)-regulated structural changes in troponin. Proc. Natl. Acad. Sci. U S A. 2005;102:5038–5043. doi: 10.1073/pnas.0408882102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Strynadka NCJ, James MNG. Crystal structures of the helix-loop-helix calcium-binding proteins. Annu. Rev. Biochem. 1989;58:951–998. doi: 10.1146/annurev.bi.58.070189.004511. [DOI] [PubMed] [Google Scholar]
  • 22.Nelson MR, Chazin WJ. Structures of EF-hand Ca(2+)-binding proteins: diversity in the organization, packing and response to Ca2+ binding. Biometals. 1998;11:297–318. doi: 10.1023/a:1009253808876. [DOI] [PubMed] [Google Scholar]
  • 23.Shaw GS, Hodges RS, Sykes BD. Calcium-induced peptide association to form an intact protein domain: 1H NMR structural evidence. Science. 1990;249:280–283. doi: 10.1126/science.2374927. [DOI] [PubMed] [Google Scholar]
  • 24.Shaw GS, Hodges RS, Kay CM, Sykes BD. Relative stabilities of synthetic peptide homo-and heterodimeric troponin-C domains. Protein Sci. 1994;3:1010–1019. doi: 10.1002/pro.5560030703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wojcik J, Goral J, Pawlowski K, Bierzynski A. Isolated calcium-binding loops of EF-hand proteins can dimerize to form a native-like structure. Biochemistry. 1997;36:680–687. doi: 10.1021/bi961821c. [DOI] [PubMed] [Google Scholar]
  • 26.Grabarek Z. Structure of a trapped intermediate of calmodulin: calcium regulation of EF-hand proteins from a new perspective. J Mol Biol. 2005;346:1351–1366. doi: 10.1016/j.jmb.2005.01.004. [DOI] [PubMed] [Google Scholar]
  • 27.Grabarek Z. Structural basis for diversity of the EF-hand calcium-binding proteins. J Mol Biol. 2006;359:509–525. doi: 10.1016/j.jmb.2006.03.066. [DOI] [PubMed] [Google Scholar]
  • 28.Gifford JL, Walsh MP, Vogel HJ. Structures and metal-ion-binding properties of the Ca2+ -binding helix-loop-helix EF-hand motifs. Biochem J. 2007;405:199–221. doi: 10.1042/BJ20070255. [DOI] [PubMed] [Google Scholar]
  • 29.Herzberg O, Moult J, James MN. A model for the Ca2+ -induced conformational transition of troponin CA trigger for muscle contraction. J. Biol. Chem. 1986;261:2638–2644. [PubMed] [Google Scholar]
  • 30.Gagne SM, Li MX, Sykes BD. Mechanism of direct coupling between binding and induced structural change in regulatory calcium binding proteins. Biochemistry. 1997;36:4386–4392. doi: 10.1021/bi963076+. [DOI] [PubMed] [Google Scholar]
  • 31.Li MX, Gagne SM, Spyracopoulos L, Kloks C, Audette G, Chandra M, Solaro RJ, Smillie LB, Sykes BD. NMR Studies of Ca2+ binding to the regulatory domains of cardiac and E41A skeletal muscle troponin C reveal the importance of site I to energetics of the induced structural changes. Biochemistry. 1997;36:12519–12525. doi: 10.1021/bi971222l. [DOI] [PubMed] [Google Scholar]
  • 32.Maune JF, Klee CB, Beckingham K. Ca2+ binding and conformational change in two series of point mutations to the individual Ca(2+)-binding sites of calmodulin. J. Biol. Chem. 1992;267:5286–5295. [PubMed] [Google Scholar]
  • 33.Starovasnik MA, Su DR, Beckingham K, Klevit RE. A series of point mutations reveal interactions between the calcium-binding sites of calmodulin. Protein Sci. 1992;17:245–253. doi: 10.1002/pro.5560010206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gao ZH, Krebs J, VanBerkum MF, Tang WJ, Maune JF, Means AR, Stull JT, Beckingham K. Activation of four enzymes by two series of calmodulin mutants with point mutations in individual Ca2+ binding sites. J. Biol. Chem. 1993;268:20096–20104. [PubMed] [Google Scholar]
  • 35.Biekofsky RR, Feeney J. Cooperative cyclic interactions involved in metal binding to pairs of sites in EF-hand proteins. FEBS Lett. 1998;439:101–106. doi: 10.1016/s0014-5793(98)01349-0. [DOI] [PubMed] [Google Scholar]
  • 36.Biekofsky RR, Martin SR, Browne JP, Bayley PM, Feeney J. Ca2+ coordination to backbone carbonyl oxygen atoms in calmodulin and other EF-hand proteins: 15N chemical shifts as probes for monitoring individual-site Ca2+ coordination. Biochemistry. 1998;37:7617–7629. doi: 10.1021/bi9800449. [DOI] [PubMed] [Google Scholar]
  • 37.Yap KL, Ames JB, Swindells MB, Ikura M. Diversity of conformational states and changes within the EF-hand protein superfamily. Proteins. 1999;37:499–507. doi: 10.1002/(sici)1097-0134(19991115)37:3<499::aid-prot17>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  • 38.Heizmann CW, Cox JA. New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. Biometals. 1998;11:383–397. doi: 10.1023/a:1009212521172. [DOI] [PubMed] [Google Scholar]
  • 39.Moroz OV, Antson AA, Grist SJ, Maitland NJ, Dodson GG, Wilson KS, Lukanidin E, Bronstein IB. Structure of the human S100A12-copper complex: implications for host-parasite defence. Acta Crystallogr D Biol Crystallogr. 2003;59:859–867. doi: 10.1107/s0907444903004700. [DOI] [PubMed] [Google Scholar]
  • 40.Moroz OV, Blagova EV, Wilkinson AJ, Wilson KS, Bronstein IB. The crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerisation. J Mol Biol. 2009;391:536–551. doi: 10.1016/j.jmb.2009.06.004. [DOI] [PubMed] [Google Scholar]
  • 41.Berridge MJ, Bootman MD, Lipp P. Calcium-a life and death signal. Nature. 1998;395:645–648. doi: 10.1038/27094. [DOI] [PubMed] [Google Scholar]
  • 42.Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1:11–21. doi: 10.1038/35036035. [DOI] [PubMed] [Google Scholar]
  • 43.Romani A, Scarpa A. Regulation of cell magnesium. Arch Biochem Biophys. 1992;298:1–12. doi: 10.1016/0003-9861(92)90086-c. [DOI] [PubMed] [Google Scholar]
  • 44.Romani AM, Scarpa A. Regulation of cellular magnesium. Front Biosci. 2000;5:D720–D734. doi: 10.2741/romani. [DOI] [PubMed] [Google Scholar]
  • 45.Romani AM, Maguire ME. Hormonal regulation of Mg2+ transport and homeostasis in eukaryotic cells. Biometals. 2002;15:271–283. doi: 10.1023/a:1016082900838. [DOI] [PubMed] [Google Scholar]
  • 46.Means AR. Molecular mechanisms of action of calmodulin. Recent Progress In Hormone Research. 1988;44:223–262. doi: 10.1016/b978-0-12-571144-9.50012-0. [DOI] [PubMed] [Google Scholar]
  • 47.Seamon KB. Calcium- and magnesium-dependent conformational states of calmodulin as determined by nuclear magnetic resonance. Biochemistry. 1980;19:207–215. doi: 10.1021/bi00542a031. [DOI] [PubMed] [Google Scholar]
  • 48.Forsen S, Thulin E, Drakenberg T, Krebs J, Seamon K. A 113Cd NMR study of calmodulin and its interaction with calcium, magnesium and trifluoperazine. FEBS Lett. 1980;117:189–194. doi: 10.1016/0014-5793(80)80942-2. [DOI] [PubMed] [Google Scholar]
  • 49.Haiech J, Klee CB, Demaille JG. Effects of cations on affinity of calmodulin for calcium: Ordered binding of calcium ions allows the specific activation of calmodulin-stimulated enzymes. Biochemistry. 1981;20:3890–3897. doi: 10.1021/bi00516a035. [DOI] [PubMed] [Google Scholar]
  • 50.Follenius A, Gerard D. Fluorescence investigations of calmodulin hydrophobic sites. Biochem Biophys Res Commun. 1984;119:1154–1160. doi: 10.1016/0006-291x(84)90896-9. [DOI] [PubMed] [Google Scholar]
  • 51.Ogawa Y, Tanokura M. Calcium binding to calmodulin: effects of ionic strength, Mg2+, pH and temperature. J Biochem (Tokyo) 1984;95:19–28. doi: 10.1093/oxfordjournals.jbchem.a134584. [DOI] [PubMed] [Google Scholar]
  • 52.Klee CB, Newton DL, Ni WC, Haiech J. Regulation of the calcium signal by calmodulin. Ciba Found. Symp. 1986;122:162–182. doi: 10.1002/9780470513347.ch10. [DOI] [PubMed] [Google Scholar]
  • 53.Tsai MD, Drakenberg T, Thulin E, Forsen S. Is the binding of magnesium (II) to calmodulin significant? An investigation by magnesium-25 nuclear magnetic resonance. Biochemistry. 1987;26:3635–3643. doi: 10.1021/bi00386a057. [DOI] [PubMed] [Google Scholar]
  • 54.Ohki SY, Ikura M, Zhang MJ. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin. Biochemistry. 1997;36:4309–4316. doi: 10.1021/bi962759m. [DOI] [PubMed] [Google Scholar]
  • 55.Malmendal A, Evenas J, Thulin E, Gippert GP, Drakenberg T, Forsen S. When size is important. Accommodation of magnesium in a calcium binding regulatory domain. J Biol Chem. 1998;273:28994–29001. doi: 10.1074/jbc.273.44.28994. [DOI] [PubMed] [Google Scholar]
  • 56.Martin SR, Masino L, Bayley PM. Enhancement by Mg2+ of domain specificity in Ca2+ -dependent interactions of calmodulin with target sequences. Protein Sci. 2000;9:2477–2488. doi: 10.1110/ps.9.12.2477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Malmendal A, Linse S, Evenas J, Forsen S, Drakenberg T. Battle for the EF-hands: magnesium-calcium interference in calmodulin. Biochemistry. 1999;38:11844–11850. doi: 10.1021/bi9909288. [DOI] [PubMed] [Google Scholar]
  • 58.Tanokura M, Yamada K. A calorimetric study of Ca2+- and Mg2+ -binding by calmodulin. J Biochem (Tokyo) 1983;94:607–609. doi: 10.1093/oxfordjournals.jbchem.a134393. [DOI] [PubMed] [Google Scholar]
  • 59.Milos M, Schaer JJ, Comte M, Cox JA. Calcium-proton and calcium-magnesium antagonisms in calmodulin: microcalorimetric and potentiometric analyses. Biochemistry. 1986;25:6279–6287. doi: 10.1021/bi00368a067. [DOI] [PubMed] [Google Scholar]
  • 60.Gilli R, Lafitte D, Lopez C, Kilhoffer M, Makarov A, Briand C, Haiech J. Thermodynamic analysis of calcium and magnesium binding to calmodulin. Biochemistry. 1998;37:5450–5456. doi: 10.1021/bi972083a. [DOI] [PubMed] [Google Scholar]
  • 61.Brzeska H, Venyaminov SV, Grabarek Z, Drabikowski W. Comparative studies on thermostability of calmodulin, skeletal muscle troponin C and their tryptic fragments. FEBS Lett. 1983;153:169–173. doi: 10.1016/0014-5793(83)80141-0. [DOI] [PubMed] [Google Scholar]
  • 62.Tsalkova TN, Privalov PL. Thermodynamic study of domain organization in troponin C and calmodulin. J. Mol. Biol. 1985;181:533–544. doi: 10.1016/0022-2836(85)90425-5. [DOI] [PubMed] [Google Scholar]
  • 63.Chao SH, Suzuki Y, Zysk JR, Cheung WY. Activation of calmodulin by various metal cations as a function of ionic radius. Mol Pharmacol. 1984;26:75–82. [PubMed] [Google Scholar]
  • 64.Gordon AM, Homsher E, Regnier M. Regulation of contraction in striated muscle. Physiol Rev. 2000;80:853–924. doi: 10.1152/physrev.2000.80.2.853. [DOI] [PubMed] [Google Scholar]
  • 65.Tobacman LS. Thin filament-mediated regulation of cardiac contraction. [Review] Annu. Rev. Physiol. 1996;58:447–481. doi: 10.1146/annurev.ph.58.030196.002311. [DOI] [PubMed] [Google Scholar]
  • 66.Geeves MA, Lehrer SS. Cooperativity in the Ca2+ regulation of muscle contraction. Results Probl Cell Differ. 2002;36:111–132. doi: 10.1007/978-3-540-46558-4_10. [DOI] [PubMed] [Google Scholar]
  • 67.Potter JD, Gergely J. The calcium and magnesium binding sites on troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J. Biol. Chem. 1975;250:4628–4633. [PubMed] [Google Scholar]
  • 68.Zot AS, Potter JD. The effect of [Mg2+] on the Ca2+ dependence of ATPase and tension development of fast skeletal muscle. The role of the Ca2+-specific sites of troponin C. J. Biol. Chem. 1987;262:1966–1969. [PubMed] [Google Scholar]
  • 69.Davis JP, Rall JA, Reiser PJ, Smillie LB, Tikunova SB. Engineering competitive magnesium binding into the first EF-hand of skeletal troponin C. J Biol Chem. 2002;277:49716–49726. doi: 10.1074/jbc.M208488200. [DOI] [PubMed] [Google Scholar]
  • 70.Robertson SP, Johnson JD, Potter JD. The time-course of Ca2+ exchange with calmodulin, troponin, parvalbumin, and myosin in response to transient increases in Ca2+ Biophys. J. 1981;34:559–569. doi: 10.1016/S0006-3495(81)84868-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Zot AS, Potter JD. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu. Rev. Biophys. Biophys. Chem. 1987;16:535–559. doi: 10.1146/annurev.bb.16.060187.002535. [DOI] [PubMed] [Google Scholar]
  • 72.Szczesna D, Guzman G, Miller T, Zhao JJ, Farokhi K, Ellemberger H, Potter JD. The role of the four Ca2+ binding sites of troponin C in the regulation of skeletal muscle contraction. J. Biol. Chem. 1996;271:8381–8386. doi: 10.1074/jbc.271.14.8381. [DOI] [PubMed] [Google Scholar]
  • 73.Grabarek Z, Tan RY, Wang J, Tao T, Gergely J. Inhibition of mutant troponin C activity by an intra-domain disulphide bond. Nature. 1990;345:132–135. doi: 10.1038/345132a0. [DOI] [PubMed] [Google Scholar]
  • 74.Grabarek Z, Drabikowski W, Leavis PC, Rosenfeld SS, Gergely J. Proteolytic fragments of troponin C. Interactions with the other troponin subunits and biological activity. J. Biol. Chem. 1981;256:13121–13127. [PubMed] [Google Scholar]
  • 75.Grabarek Z, Grabarek J, Leavis PC, Gergely J. Cooperative binding to the Ca2+ -specific sites of troponin C in regulated actin and actomyosin. J. Biol. Chem. 1983;258:14098–14102. [PubMed] [Google Scholar]
  • 76.Francois JM, Sheng Z, Szczesna D, Potter JD. The functional role of the domains of troponin-C investigated with thrombin fragments of troponin-C reconstituted into skinned muscle fibers. J. Biol. Chem. 1995;270:19287–19293. doi: 10.1074/jbc.270.33.19287. [DOI] [PubMed] [Google Scholar]
  • 77.Grabarek Z, Leavis PC, Gergely J. Calcium binding to the low affinity sites in troponin C induces conformational changes in the high affinity domain. A possible route of information transfer in activation of muscle contraction. J. Biol. Chem. 1986;261:608–613. [PubMed] [Google Scholar]
  • 78.Kawasaki Y, Van Eerd JP. The effect of Mg ++ on the conformation of the Ca ++ -binding component of troponin. Biochem. Biophys. Res. Commun. 1972;49:898–905. doi: 10.1016/0006-291x(72)90297-5. [DOI] [PubMed] [Google Scholar]
  • 79.Seamon KB, Hartshorne DJ, Bothner-By AA. Ca2+ and Mg2+ dependent conformations of troponin C as determined by 1H and 19F nuclear magnetic resonance. Biochemistry. 1977;16:4039–4046. doi: 10.1021/bi00637a016. [DOI] [PubMed] [Google Scholar]
  • 80.Levine BA, Thornton JM, Fernandes R, Kelly CM, Mercola D. Comparison of the calcium- and magnesium-induced structural changes of troponin-C. A proton magnetic resonance study. Biochim. Biophys. Acta. 1978;535:11–24. doi: 10.1016/0005-2795(78)90028-4. [DOI] [PubMed] [Google Scholar]
  • 81.Vassylyev DG, Takeda S, Wakatsuki S, Maeda K, Maeda Y. Crystal structure of troponin C in complex with troponin I fragment at 2.3-A resolution. Proc Natl Acad Sci U S A. 1998;95:4847–4852. doi: 10.1073/pnas.95.9.4847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Finley NL, Howarth JW, Rosevear PR. Structure of the Mg2+-loaded C-lobe of cardiac troponin C bound to the N-domain of cardiac troponin I: comparison with the Ca2+-loaded structure. Biochemistry. 2004;43:11371–11379. doi: 10.1021/bi049672i. [DOI] [PubMed] [Google Scholar]
  • 83.Agianian B, Krzic U, Qiu F, Linke WA, Leonard K, Bullard B. A troponin switch that regulates muscle contraction by stretch instead of calcium. EMBO J. 2004;23:772–779. doi: 10.1038/sj.emboj.7600097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Boussouf SE, Agianian B, Bullard B, Geeves MA. The regulation of Myosin binding to actin filaments by lethocerus troponin. J Mol Biol. 2007;373:587–598. doi: 10.1016/j.jmb.2007.07.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.De Nicola G, Burkart C, Qiu F, Agianian B, Labeit S, Martin S, Bullard B, Pastore A. The structure of Lethocerus troponin C: insights into the mechanism of stretch activation in muscles. Structure. 2007;15:813–824. doi: 10.1016/j.str.2007.05.007. [DOI] [PubMed] [Google Scholar]
  • 86.Marenholz I, Lovering RC, Heizmann CW. An update of the S100 nomenclature. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2006;1763:1282–1283. doi: 10.1016/j.bbamcr.2006.07.013. [DOI] [PubMed] [Google Scholar]
  • 87.Andersson M, Malmendal A, Linse S, Ivarsson I, Forsen S, Svensson LA. Structural basis for the negative allostery between Ca(2+)- and Mg(2+)- binding in the intracellular Ca(2+)-receptor calbindin D9k. Protein Sci. 1997;6:1139–1147. doi: 10.1002/pro.5560060602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Declercq JP, Tinant B, Parello J, Rambaud J. Ionic interactions with parvalbumins. Crystal structure determination of pike 4.10 parvalbumin in four different ionic environments. J Mol Biol. 1991;220:1017–1039. doi: 10.1016/0022-2836(91)90369-h. [DOI] [PubMed] [Google Scholar]
  • 89.Kumar VD, Lee L, Edwards BF. Refined crystal structure of calcium-liganded carp parvalbumin 4.25 at 1.5-A resolution. Biochemistry. 1990;29:1404–1412. doi: 10.1021/bi00458a010. [DOI] [PubMed] [Google Scholar]
  • 90.Shannon RD. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr. 1976;A32:751–767. [Google Scholar]
  • 91.Cates MS, Teodoro ML, Phillips GN., Jr Molecular mechanisms of calcium and magnesium binding to parvalbumin. Biophys J. 2002;82:1133–1146. doi: 10.1016/S0006-3495(02)75472-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Houdusse A, Cohen C. Structure of the regulatory domain of scallop myosin at 2 angstrom resolution - implications for regulation. Structure. 1996;4:21–32. doi: 10.1016/s0969-2126(96)00006-8. [DOI] [PubMed] [Google Scholar]
  • 93.da Silva AC, Kendrick-Jones J, Reinach FC. Determinants of ion specificity on EF-hands sites. Conversion of the Ca2+/Mg2+ site of smooth muscle myosin regulatory light chain into a Ca(2+)-specific site. J. Biol. Chem. 1995;270:6773–6778. doi: 10.1074/jbc.270.12.6773. [DOI] [PubMed] [Google Scholar]
  • 94.Cates MS, Berry MB, Ho EL, Li Q, Potter JD, Phillips GN., Jr Metal-ion affinity and specificity in EF-hand proteins: coordination geometry and domain plasticity in parvalbumin. Structure Fold Des. 1999;7:1269–1278. doi: 10.1016/s0969-2126(00)80060-x. [DOI] [PubMed] [Google Scholar]
  • 95.Maguire ME, Cowan JA. Magnesium chemistry and biochemistry. Biometals. 2002;15:203–210. doi: 10.1023/a:1016058229972. [DOI] [PubMed] [Google Scholar]
  • 96.Maguire ME. Magnesium transporters: properties, regulation and structure. Front Biosci. 2006;11:3149–3163. doi: 10.2741/2039. [DOI] [PubMed] [Google Scholar]
  • 97.Einspahr H, Bugg CE. The geometry of calcium-carboxylate interactions in crystalline complexes. Acta Crystallogr. 1981;B37:1044–1052. [Google Scholar]
  • 98.Carrell CJ, Carrell HL, Erlebacher J, Glusker JP. Structural aspects of metal-ion carboxylate interactions. J. Amer. Chem. Soc. 1988;110:8651–8656. [Google Scholar]
  • 99.Jurado LA, Chockalingam PS, Jarrett HW. Apocalmodulin. Physiol Rev. 1999;79:661–682. doi: 10.1152/physrev.1999.79.3.661. [DOI] [PubMed] [Google Scholar]
  • 100.Black DJ, Leonard J, Persechini A. Biphasic Ca2+-dependent switching in a calmodulin-IQ domain complex. Biochemistry. 2006;45:6987–6995. doi: 10.1021/bi052533w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Gomes AV, Potter JD. Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene. Mol Cell Biochem. 2004;263:99–114. doi: 10.1023/B:MCBI.0000041852.42291.aa. [DOI] [PubMed] [Google Scholar]
  • 102.Solaro RJ. Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins. J Biol Chem. 2008;283:26829–26833. doi: 10.1074/jbc.R800037200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Means AR. Regulatory cascades involving calmodulin-dependent protein kinases. Mol Endocrinol. 2000;14:4–13. doi: 10.1210/mend.14.1.0414. [DOI] [PubMed] [Google Scholar]
  • 104.Keenan D, Romani A, Scarpa A. Differential regulation of circulating Mg2+ in the rat by beta 1- and beta 2-adrenergic receptor stimulation. Circ Res. 1995;77:973–983. doi: 10.1161/01.res.77.5.973. [DOI] [PubMed] [Google Scholar]
  • 105.Romani AM. Magnesium homeostasis in mammalian cells. Front Biosci. 2007;12:308–331. doi: 10.2741/2066. [DOI] [PubMed] [Google Scholar]
  • 106.Seelig MS. Skeletal and renal abnormalities. New York, NY: Goldwater Memorial Hospital, New York University Medical Center; 1980. Magnesium deficiency in the pathogenesis of disease. Early roots of cardiovascular. [Google Scholar]
  • 107.Rayssiguier Y, Mbega JD, Durlach V, Gueux E, Durlach J, Giry J, Dalle M, Mazur A, Laurant P, Berthelot A. Magnesium and blood pressure. I. Animal studies. Magnes Res. 1992;5:139–146. [PubMed] [Google Scholar]
  • 108.Touyz RM. Magnesium in clinical medicine. Front Biosci. 2004;9:1278–1293. doi: 10.2741/1316. [DOI] [PubMed] [Google Scholar]
  • 109.Weglicki W, Quamme G, Tucker K, Haigney M, Resnick L. Potassium, magnesium, and electrolyte imbalance and complications in disease management. Clin Exp Hypertens. 2005;27:95–112. doi: 10.1081/ceh-200044275. [DOI] [PubMed] [Google Scholar]
  • 110.Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys. 2007;458:48–56. doi: 10.1016/j.abb.2006.03.031. [DOI] [PubMed] [Google Scholar]
  • 111.Rosanoff A, Seelig MS. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr. 2004;23:501S–505S. doi: 10.1080/07315724.2004.10719389. [DOI] [PubMed] [Google Scholar]
  • 112.Chattopadhyaya R, Meador WE, Means AR, Quiocho FA. Calmodulin structure refined at 1.7 A resolution. J. Mol. Biol. 1992;228:1177–1192. doi: 10.1016/0022-2836(92)90324-d. [DOI] [PubMed] [Google Scholar]
  • 113.Schumacher MA, Crum M, Miller MC. Crystal structures of apocalmodulin and an apocalmodulin/SK potassium channel gating domain complex. Structure (Camb) 2004;12:849–860. doi: 10.1016/j.str.2004.03.017. [DOI] [PubMed] [Google Scholar]
  • 114.Bondi A. van der Waals Volumes and Radii. The Journal of Physical Chemistry. 1964;68:441–451. [Google Scholar]
  • 115.Svensson LA, Thulin E, Forsen S. Proline cis-trans isomers in calbindin D9k observed by X-ray crystallography. J. Mol. Biol. 1992;223:601–606. doi: 10.1016/0022-2836(92)90976-q. [DOI] [PubMed] [Google Scholar]
  • 116.DeLano WL. The PyMOL Molecular Graphics System. Palo Alto, CA, USA: DeLano Scientific; 2002. [Google Scholar]

RESOURCES